Jianke, the largest online B2C pharmacy platform in China, has closed a $130-million series B financing round led by Shenzhen-based healthcare-dedicated investment firm GTJA Investment Group, according to the company’s announcement on Tuesday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
